 |
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Cytovene.
No reviews have yet been submitted. Be the first to review this drug.
Abstract Receives "BEST ABSTRACTS AWARD FOR CLINICAL RESEARCH" at 2012 BMT Tandem Meetings on February 3rd, 2012 RESEARCH TRIANGLE PARK, N.C., Jan. 25, 2012...
Vical Incorporated (Nasdaq:VICL) today announced the online publication of a new article1 in The Lancet Infectious Diseases detailing results from the...
CMX001 shows no nephrotoxicity or myelosuppression in 183 patients treated under emergency INDs DURHAM, N.C., Sept. 16, 2011 /PRNewswire/ -- Chimerix,...
A new study finds that a saliva test in newborns can detect almost all cases of a virus that can cause birth defects and hearing loss. The test could allow...
Vical Incorporated (Nasdaq:VICL) announced today that Vical is presenting on the company's TransVaxT therapeutic cytomegalovirus (CMV) vaccine, and its CMV...
Looking for answers? Ask a question or go join the Cytovene support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
